Oligomer-specific Aβ toxicity in cell models is mediated by selective uptake

被引:95
作者
Chafekar, Sidhartha M. [1 ]
Baas, Frank [2 ]
Scheper, Wiep [1 ,2 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Neurogenet Lab, NL-1100 DD Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1100 DD Amsterdam, Netherlands
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2008年 / 1782卷 / 09期
关键词
Alzheimer's disease; beta-amyloid; aggregation; oligomer; toxicity; uptake;
D O I
10.1016/j.bbadis.2008.06.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is characterized by the aggregation and subsequent deposition of misfolded beta-amyloid (A beta) peptide. Previous studies show that aggregated A beta is more toxic in oligomeric than in fibrillar form, and that each aggregation form activates specific molecular pathways in the cell. We hypothesize that these differences between oligomers and fibrils are related to their different accessibility to the intracellular space. To this end we used fluorescently labelled A beta(1-42) and demonstrate that A beta(1-42) oligomers readily enter both HeLa and differentiated SK N SH cells whereas fibrillar A beta(1-42) is not internalized. Oligomeric A beta(1-42) is internalized by an endocytic process and is transported to the lysosomes. Inhibition of uptake specifically inhibits oligomer but not fibril toxicity. Our study indicates that selective uptake of oligomers is a determinant of oligomer specific A beta toxicity. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:523 / 531
页数:9
相关论文
共 71 条
  • [1] A cell biological perspective on Alzheimer's disease
    Annaert, W
    De Strooper, B
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2002, 18 : 25 - 51
  • [2] Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding
    Bateman, David A.
    McLaurin, JoAnne
    Chakrabartty, Avijit
    [J]. BMC NEUROSCIENCE, 2007, 8 (1)
  • [3] Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice
    Billings, LM
    Oddo, S
    Green, KN
    McGaugh, JL
    LaFerla, FM
    [J]. NEURON, 2005, 45 (05) : 675 - 688
  • [4] Cataldo AM, 1996, ADV EXP MED BIOL, V389, P271
  • [5] Endocytic pathway abnormalities precede amyloid β deposition in sporadic Alzheimer's disease and Down syndrome -: Differential effects of APOE genotype and presenilin mutations
    Cataldo, AM
    Peterhoff, CM
    Troncosco, JC
    Gomez-Isla, T
    Hyman, BT
    Nixon, RA
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (01) : 277 - 286
  • [6] Aβ localization in abnormal endosomes:: association with earliest Aβ elevations in AD and Down syndrome
    Cataldo, AM
    Petanceska, S
    Terio, NB
    Peterhoff, CM
    Durham, R
    Mercken, M
    Mehta, PD
    Buxbaum, J
    Haroutunian, V
    Nixon, RA
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 (10) : 1263 - 1272
  • [7] CECCHI C, 2008, J CELL MOL MED
  • [8] Aβ1-42 induces mild endoplasmic reticulum stress in an aggregation state-dependent manner
    Chafekar, Sidhartha M.
    Hoozemans, Jeroen J. M.
    Zwart, Rob
    Baas, Frank
    Scheper, Wiep
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2007, 9 (12) : 2245 - 2254
  • [9] Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes
    Chithrani, B. Devika
    Chan, Warren C. W.
    [J]. NANO LETTERS, 2007, 7 (06) : 1542 - 1550
  • [10] Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells
    Chithrani, BD
    Ghazani, AA
    Chan, WCW
    [J]. NANO LETTERS, 2006, 6 (04) : 662 - 668